These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 19741570)

  • 1. Support for the involvement of the KCNK2 gene in major depressive disorder and response to antidepressant treatment.
    Liou YJ; Chen TJ; Tsai SJ; Yu YW; Cheng CY; Hong CJ
    Pharmacogenet Genomics; 2009 Oct; 19(10):735-41. PubMed ID: 19741570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of catechol-O-methyltransferase SNPs and haplotypes on treatment response phenotypes in major depressive disorder: a case-control association study.
    Kocabas NA; Faghel C; Barreto M; Kasper S; Linotte S; Mendlewicz J; Noro M; Oswald P; Souery D; Zohar J; Massat I
    Int Clin Psychopharmacol; 2010 Jul; 25(4):218-27. PubMed ID: 20531207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between the 5-HT6 receptor C267T polymorphism and response to antidepressant treatment in major depressive disorder.
    Lee SH; Lee KJ; Lee HJ; Ham BJ; Ryu SH; Lee MS
    Psychiatry Clin Neurosci; 2005 Apr; 59(2):140-5. PubMed ID: 15823158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Haplotype analysis of single nucleotide polymorphisms in the vascular endothelial growth factor (VEGFA) gene and antidepressant treatment response in major depressive disorder.
    Tsai SJ; Hong CJ; Liou YJ; Chen TJ; Chen ML; Hou SJ; Yen FC; Yu YW
    Psychiatry Res; 2009 Sep; 169(2):113-7. PubMed ID: 19700204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The interleukin 1 beta (IL1B) gene is associated with failure to achieve remission and impaired emotion processing in major depression.
    Baune BT; Dannlowski U; Domschke K; Janssen DG; Jordan MA; Ohrmann P; Bauer J; Biros E; Arolt V; Kugel H; Baxter AG; Suslow T
    Biol Psychiatry; 2010 Mar; 67(6):543-9. PubMed ID: 20044070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic association analysis of functional polymorphisms in neuronal nitric oxide synthase 1 gene (NOS1) and mood disorders and fluvoxamine response in major depressive disorder in the Japanese population.
    Okumura T; Kishi T; Okochi T; Ikeda M; Kitajima T; Yamanouchi Y; Kinoshita Y; Kawashima K; Tsunoka T; Inada T; Ozaki N; Iwata N
    Neuropsychobiology; 2010; 61(2):57-63. PubMed ID: 20016223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of serotonin-related genes affects short-term antidepressant response in major depressive disorder.
    Lin E; Chen PS; Chang HH; Gean PW; Tsai HC; Yang YK; Lu RB
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Oct; 33(7):1167-72. PubMed ID: 19560507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association study of p11 gene with major depressive disorder, suicidal behaviors and treatment response.
    Tzang RF; Hong CJ; Liou YJ; Yu YW; Chen TJ; Tsai SJ
    Neurosci Lett; 2008 Dec; 447(1):92-5. PubMed ID: 18838110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association study of the serotonin transporter promoter polymorphism and mirtazapine antidepressant response in major depressive disorder.
    Kang RH; Wong ML; Choi MJ; Paik JW; Lee MS
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Aug; 31(6):1317-21. PubMed ID: 17618721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain-derived neurotrophic factor gene polymorphism (Val66Met) and citalopram response in major depressive disorder.
    Choi MJ; Kang RH; Lim SW; Oh KS; Lee MS
    Brain Res; 2006 Nov; 1118(1):176-82. PubMed ID: 16979146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for a relationship between genetic variants at the brain-derived neurotrophic factor (BDNF) locus and major depression.
    Schumacher J; Jamra RA; Becker T; Ohlraun S; Klopp N; Binder EB; Schulze TG; Deschner M; Schmäl C; Höfels S; Zobel A; Illig T; Propping P; Holsboer F; Rietschel M; Nöthen MM; Cichon S
    Biol Psychiatry; 2005 Aug; 58(4):307-14. PubMed ID: 16005437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TPH2 -703G/T SNP may have important effect on susceptibility to suicidal behavior in major depression.
    Yoon HK; Kim YK
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Apr; 33(3):403-9. PubMed ID: 19162119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of the potassium channel gene KCNK2 in major depressive disorder.
    Congiu C; Minelli A; Bonvicini C; Bortolomasi M; Sartori R; Maj C; Scassellati C; Maina G; Trabucchi L; Segala M; Gennarelli M
    Psychiatry Res; 2015 Feb; 225(3):489-92. PubMed ID: 25535009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of the adrenergic alpha 2a receptor--1291C/G polymorphism with weight change and treatment response to mirtazapine in patients with major depressive disorder.
    Lee HY; Kang RH; Paik JW; Jeong YJ; Chang HS; Han SW; Lee MS
    Brain Res; 2009 Mar; 1262():1-6. PubMed ID: 19401164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of COMT gene polymorphisms on suicidality in treatment resistant major depressive disorder--a European multicenter study.
    Schosser A; Calati R; Serretti A; Massat I; Kocabas NA; Papageorgiou K; Linotte S; Mendlewicz J; Souery D; Zohar J; Juven-Wetzler A; Montgomery S; Kasper S
    Eur Neuropsychopharmacol; 2012 Apr; 22(4):259-66. PubMed ID: 21940152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between the tryptophan hydroxylase-1 gene A218C polymorphism and citalopram antidepressant response in a Korean population.
    Ham BJ; Lee BC; Paik JW; Kang RH; Choi MJ; Choi IG; Lee MS
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan; 31(1):104-7. PubMed ID: 16979275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Common genetic variations in human brain-specific tryptophan hydroxylase-2 and response to antidepressant treatment.
    Tzvetkov MV; Brockmöller J; Roots I; Kirchheiner J
    Pharmacogenet Genomics; 2008 Jun; 18(6):495-506. PubMed ID: 18496129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical milestones predict symptom remission over 6-month and choice of treatment of patients with major depressive disorder (MDD).
    Wade AG; Schlaepfer TE; Andersen HF; Kilts CD
    J Psychiatr Res; 2009 Feb; 43(5):568-75. PubMed ID: 18954875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ACE polymorphism and response to electroconvulsive therapy in major depression.
    Stewart JA; Kampman O; Huuhka M; Anttila S; Huuhka K; Lehtimäki T; Leinonen E
    Neurosci Lett; 2009 Jul; 458(3):122-5. PubMed ID: 19409959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RGS4 polymorphism and response to electroconvulsive therapy in major depressive disorder.
    Huuhka K; Kampman O; Anttila S; Huuhka M; Rontu R; Mattila KM; Hurme M; Lehtimäki T; Leinonen E
    Neurosci Lett; 2008 May; 437(1):25-8. PubMed ID: 18434012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.